{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:51Z","timestamp":1792785051877,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn","id":[{"id":"https:\/\/ror.org\/041nas322","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sickle cell disease (SCD) is characterized by chronic inflammation and immune dysfunction, yet the underlying signaling defects and their relationship with cellular and systemic immune profiles remain incompletely understood, particularly across different genotypes (HbSS vs HbSC) in pediatric populations. This study characterized the immune landscape in children with SCD. We conducted a case-control study with 53 children with SCD (HbSS and HbSC genotypes) and 27 healthy children with the HbAA genotype. The phenotypes of T helper cells and the phosphorylation status of their STAT proteins were characterised using flow cytometry.\u00a0Cytokine levels in systemic circulation were quantified using Sandwich ELISA. Children with the HbSC genotype showed significant reductions in CD4\n                    <jats:sup>+<\/jats:sup>\n                    Tbet\n                    <jats:sup>+<\/jats:sup>\n                    IFN-\u03b3\n                    <jats:sup>+<\/jats:sup>\n                    (Th1) and CD4\n                    <jats:sup>+<\/jats:sup>\n                    Foxp3\n                    <jats:sup>+<\/jats:sup>\n                    IL-10\n                    <jats:sup>+<\/jats:sup>\n                    (Treg) cell populations compared to healthy controls. SCD patients exhibited low activation of STAT1, STAT2, STAT4, STAT5, and STAT6 pathways, along with decreased circulating levels of IL-1\u03b2, IL-6, TNF-\u03b1, IFN-\u03b3, and IL-10. In contrast, IL-17A (Th17) and IL-5 (Th2) levels did not differ between groups. In untreated pediatric SCD, we observed STAT downregulation, Th1\/Treg deficits, and decreased IL-1\u03b2, TNF-\u03b1, IL-6, IFN-\u03b3, and IL-10, with preserved Th2\/Th17 responses. HbSS and HbSC showed minimal differences, suggesting a shared impairment of the STAT-Th1-IFN-\u03b3 axis.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-60783-5","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:33:07Z","timestamp":1784043187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Downregulation of cytokine responses and STAT signaling in children with sickle cell disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Bassimtou","family":"Mazou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gnatoulma","family":"Katawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fagd\u00e9ba David","family":"Bara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edlom P\u00e9lagie","family":"Tchadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e9gmaba","family":"Gnodja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e8zouw\u00e8","family":"Magnang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mal\u00e9w\u00e9","family":"Kolou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"60783_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cyto.2014.11.030","volume":"72","author":"S Sarray","year":"2015","unstructured":"Sarray, S. et al. Serum IL-6, IL-10, and TNF\u03b1 levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition. Cytokine 72, 43\u201347 (2015).","journal-title":"Cytokine"},{"key":"60783_CR2","doi-asserted-by":"crossref","first-page":"1630994","DOI":"10.3389\/fphar.2025.1630994","volume":"16","author":"M Taher","year":"2025","unstructured":"Taher, M. et al. Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches. Front. Pharmacol. 16, 1630994 (2025).","journal-title":"Front. Pharmacol."},{"key":"60783_CR3","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1182\/blood.2024024608","volume":"144","author":"C Caruso","year":"2024","unstructured":"Caruso, C. et al. Less-deformable erythrocyte subpopulations biomechanically induce endothelial inflammation in sickle cell disease. Blood 144, 2050\u20132062 (2024).","journal-title":"Blood"},{"key":"60783_CR4","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1073\/pnas.1424111112","volume":"112","author":"E Du","year":"2015","unstructured":"Du, E. et al. Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis. Proc. Natl. Acad. Sci. U.S.A. 112, 1422 (2015).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"60783_CR5","doi-asserted-by":"publisher","unstructured":"The delay time. in sickle cell disease after 40 years: A paradigm assessed: The Delay Time in Sickle Cell Disease | Request PDF. ResearchGate. https:\/\/doi.org\/10.1002\/ajh.23958","DOI":"10.1002\/ajh.23958"},{"key":"60783_CR6","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.052522799","volume":"99","author":"A Turhan","year":"2002","unstructured":"Turhan, A. et al. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc. Natl. Acad. Sci. U S A. 99, 3047\u20133051 (2002).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"60783_CR7","doi-asserted-by":"crossref","first-page":"104202","DOI":"10.1016\/j.lpm.2023.104202","volume":"52","author":"P Connes","year":"2023","unstructured":"Connes, P. et al. Vascular pathophysiology of sickle cell disease. Presse Med. 52, 104202 (2023).","journal-title":"Presse Med."},{"key":"60783_CR8","unstructured":"Karna, B., Jha, S. K. & Al Zaabi, E. Hemoglobin C Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing, (2025). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559043\/ accessed 25 July 2025)."},{"key":"60783_CR9","unstructured":"A, D. A. & Rb, R. K, et al. Sickle Cell. Trait PubMed, https:\/\/pubmed.ncbi.nlm.nih.gov\/30725815\/ (2025). accessed 25 July 2025)."},{"key":"60783_CR10","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel, F. B., Steinberg, M. H. & Rees, D. C. Sickle Cell Disease. N Engl. J. Med. 376, 1561\u20131573 (2017).","journal-title":"N Engl. J. Med."},{"key":"60783_CR11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.crci.2016.02.019","volume":"19","author":"PT Mpiana","year":"2016","unstructured":"Mpiana, P. T., Ngbolua, K-N. & Tshibangu, S. T. D. Functional foods and sickle cell disease: a brief review. C. R. Chim. 19, 884\u2013889 (2016).","journal-title":"C. R. Chim."},{"key":"60783_CR12","first-page":"81","volume":"31","author":"JP Ambe","year":"2012","unstructured":"Ambe, J. P. et al. Clinical features of sickle cell anaemia in northern nigerian children. West. Afr. J. Med. 31, 81\u201385 (2012).","journal-title":"West. Afr. J. Med."},{"key":"60783_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s13104-019-4682-5","volume":"12","author":"MA Adam","year":"2019","unstructured":"Adam, M. A., Adam, N. K. & Mohamed, B. A. Prevalence of sickle cell disease and sickle cell trait among children admitted to Al Fashir Teaching Hospital North Darfur State, Sudan. BMC Res. Notes. 12, 659 (2019).","journal-title":"BMC Res. Notes"},{"key":"60783_CR14","unstructured":"Aim\u00e9, A. K. et al. Sociodemographic and medical history data of SS sickle cell patients identified in a pediatric hospital in Kindu, Democratic Republic of the Congo."},{"key":"60783_CR15","doi-asserted-by":"crossref","first-page":"617962","DOI":"10.3389\/fimmu.2020.617962","volume":"11","author":"R Sesti-Costa","year":"2020","unstructured":"Sesti-Costa, R. et al. Inflammatory Dendritic Cells Contribute to Regulate the Immune Response in Sickle Cell Disease. Front. Immunol. 11, 617962 (2020).","journal-title":"Front. Immunol."},{"key":"60783_CR16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/trf.15619","volume":"60","author":"PF Blatyta","year":"2020","unstructured":"Blatyta, P. F. et al. Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease. Transfusion 60, 343\u2013350 (2020).","journal-title":"Transfusion"},{"key":"60783_CR17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato, G. J., Steinberg, M. H. & Gladwin, M. T. Intravascular hemolysis and the pathophysiology of sickle cell disease. J. Clin. Invest. 127, 750\u2013760 (2017).","journal-title":"J. Clin. Invest."},{"key":"60783_CR18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fimmu.2020.00454","volume":"11","author":"E Nader","year":"2020","unstructured":"Nader, E., Romana, M. & Connes, P. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease. Front. Immunol. 11, 454 (2020).","journal-title":"Front. Immunol."},{"key":"60783_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13045-021-01214-y","volume":"14","author":"N Awasthi","year":"2021","unstructured":"Awasthi, N., Liongue, C. & Ward, A. C. STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer. J. Hematol. Oncol. 14, 198 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"60783_CR20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/imr.13146","volume":"314","author":"LS Torres","year":"2023","unstructured":"Torres, L. S. & Hidalgo, A. Neutrophils as drivers of vascular injury in sickle cell disease. Immunol. Rev. 314, 302\u2013312 (2023).","journal-title":"Immunol. Rev."},{"key":"60783_CR21","doi-asserted-by":"crossref","unstructured":"Serra, M. et al. IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-skewed Hematopoiesis in Sickle Cell Anemia. Res Sq ; (2025). rs.3.rs-7766748.","DOI":"10.21203\/rs.3.rs-7766748\/v1"},{"key":"60783_CR22","doi-asserted-by":"crossref","first-page":"1110765","DOI":"10.3389\/fbioe.2023.1110765","volume":"11","author":"Q Hu","year":"2023","unstructured":"Hu, Q. et al. JAK\/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. Front. Bioeng. Biotechnol. 11, 1110765 (2023).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"60783_CR23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.molimm.2018.12.005","volume":"115","author":"A Vargas-Hern\u00e1ndez","year":"2019","unstructured":"Vargas-Hern\u00e1ndez, A. & Forbes, L. R. JAK\/STAT proteins and their biological impact on NK cell development and function. Mol. Immunol. 115, 21\u201330 (2019).","journal-title":"Mol. Immunol."},{"key":"60783_CR24","doi-asserted-by":"crossref","first-page":"e27642","DOI":"10.1002\/pbc.27642","volume":"66","author":"ME Yee","year":"2019","unstructured":"Yee, M. E. et al. Incidence of invasive Haemophilus influenzae infections in children with sickle cell disease. Pediatr. Blood Cancer. 66, e27642 (2019).","journal-title":"Pediatr. Blood Cancer"},{"key":"60783_CR25","doi-asserted-by":"crossref","first-page":"e0218880","DOI":"10.1371\/journal.pone.0218880","volume":"15","author":"S Kelly","year":"2020","unstructured":"Kelly, S. et al. Influence of sickle cell disease on susceptibility to HIV infection. PLoS One. 15, e0218880 (2020).","journal-title":"PLoS One"},{"key":"60783_CR26","unstructured":"Inflammatory signatures during. the steady state of sickle cell disease in African children. Sciety, (2025). https:\/\/sciety.org\/articles\/activity\/10.21203\/rs.3.rs-3729923\/v1?utm accessed 3 April 2026)."},{"key":"60783_CR27","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","volume":"17","author":"Q Chen","year":"2016","unstructured":"Chen, Q., Sun, L. & Chen, Z. J. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nat. Immunol. 17, 1142\u20131149 (2016).","journal-title":"Nat. Immunol."},{"key":"60783_CR28","doi-asserted-by":"crossref","first-page":"10001","DOI":"10.70322\/bgd.2025.10001","volume":"9","author":"AP Reiner","year":"2025","unstructured":"Reiner, A. P. et al. Alterations of T Cell Subsets Associated with Sickle Cell Trait. Blood Genom Discov. 9, 10001 (2025).","journal-title":"Blood Genom Discov"},{"key":"60783_CR29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/imm.70080","volume":"177","author":"S Jamwal","year":"2026","unstructured":"Jamwal, S. et al. Unravelling the Immunological Enigma of Sickle Cell Disease: Current Understanding and Future Directions. Immunology 177, 445\u2013456 (2026).","journal-title":"Immunology"},{"key":"60783_CR30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout, A. et al. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. 21, 548\u2013569 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"60783_CR31","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s12276-023-00965-7","volume":"55","author":"J Kim","year":"2023","unstructured":"Kim, J., Kim, H-S. & Chung, J. H. Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway. Exp. Mol. Med. 55, 510\u2013519 (2023).","journal-title":"Exp. Mol. Med."},{"key":"60783_CR32","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3324\/haematol.2024.285066","volume":"110","author":"LEA Scourfield","year":"2025","unstructured":"Scourfield, L. E. A. et al. Infections in sickle cell disease. Haematologica 110, 546\u2013561 (2025).","journal-title":"Haematologica"},{"key":"60783_CR33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4314\/ahs.v25i1.36","volume":"25","author":"S Patel","year":"2025","unstructured":"Patel, S. et al. Cytokine and immune cell interaction in immune-inflammatory response during crisis event in sickle cell disease. Afr. Health Sci. 25, 474\u2013497 (2025).","journal-title":"Afr. Health Sci."},{"key":"60783_CR34","doi-asserted-by":"crossref","first-page":"e0228399","DOI":"10.1371\/journal.pone.0228399","volume":"15","author":"CC da Guarda","year":"2020","unstructured":"da Guarda, C. C. et al. Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC). PLoS One. 15, e0228399 (2020).","journal-title":"PLoS One"},{"key":"60783_CR35","doi-asserted-by":"publisher","unstructured":"Gee, B. E. et al. Whole Blood Transcriptome Analysis in Children with Sickle Cell Anemia. Front Genet; 12. Epub ahead of print 13 January 2022. https:\/\/doi.org\/10.3389\/fgene.2021.737741","DOI":"10.3389\/fgene.2021.737741"},{"key":"60783_CR36","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","volume":"14","author":"PT McGann","year":"2015","unstructured":"McGann, P. T. & Ware, R. E. Hydroxyurea therapy for sickle cell anemia. Expert Opin. Drug Saf. 14, 1749\u20131758 (2015).","journal-title":"Expert Opin. Drug Saf."},{"key":"60783_CR37","doi-asserted-by":"publisher","unstructured":"Terrigno, K. et al. Higher aged neutrophils and differential inflammatory profiles in sickle cell disease patients on chronic transfusion therapy versus those on hydroxyurea. Front Immunol ; 16. Epub ahead of print 26 September 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1671061","DOI":"10.3389\/fimmu.2025.1671061"},{"key":"60783_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ni.3691","volume":"18","author":"AV Villarino","year":"2017","unstructured":"Villarino, A. V., Kanno, Y. & O\u2019Shea, J. J. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat. Immunol. 18, 374\u2013384 (2017).","journal-title":"Nat. Immunol."},{"key":"60783_CR39","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1182\/blood-2006-11-055756","volume":"109","author":"Z Yao","year":"2007","unstructured":"Yao, Z. et al. Nonredundant roles for Stat5a\/b in directly regulating Foxp3. Blood 109, 4368\u20134375 (2007).","journal-title":"Blood"},{"key":"60783_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/382174a0","volume":"382","author":"MH Kaplan","year":"1996","unstructured":"Kaplan, M. H. et al. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174\u2013177 (1996).","journal-title":"Nature"},{"key":"60783_CR41","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/annrheumdis-2018-213524","volume":"77","author":"R Carapito","year":"2018","unstructured":"Carapito, R. et al. Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency. Ann. Rheum. Dis. 77, 1675\u20131687 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"60783_CR42","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3324\/haematol.2024.285066","volume":"110","author":"LEA Scourfield","year":"2024","unstructured":"Scourfield, L. E. A. et al. Infections in sickle cell disease. Haematologica 110, 546\u2013561 (2024).","journal-title":"Haematologica"},{"key":"60783_CR43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/thalassrep13030019","volume":"13","author":"T Sahu","year":"2023","unstructured":"Sahu, T. et al. Infection and Potential Challenge of Childhood Mortality in Sickle Cell Disease: A Comprehensive Review of the Literature from a Global Perspective. Thalassemia Rep. 13, 206\u2013229 (2023).","journal-title":"Thalassemia Rep."},{"key":"60783_CR44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.12170","volume":"259","author":"KS Smigiel","year":"2014","unstructured":"Smigiel, K. S. et al. Regulatory T cell homeostasis: steady-state maintenance and modulation during inflammation. Immunol. Rev. 259, 40\u201359 (2014).","journal-title":"Immunol. Rev."},{"key":"60783_CR45","doi-asserted-by":"crossref","unstructured":"Daltro, P. B. et al. CD4\u2009+\u2009T Cell Profile and Activation Response in Sickle Cell Disease Patients with Osteonecrosis. Mediators of Inflammation ; 2020: 1747894. (2020).","DOI":"10.1155\/2020\/1747894"},{"key":"60783_CR46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.exphem.2016.03.008","volume":"44","author":"SC Olenscki Gilli","year":"2016","unstructured":"Olenscki Gilli, S. C. et al. Cytokine polymorphisms in sickle cell disease and the relationship with cytokine expression. Exp. Hematol. 44, 583\u2013589 (2016).","journal-title":"Exp. Hematol."},{"key":"60783_CR47","doi-asserted-by":"publisher","unstructured":"Marchesani, S. et al. Inflammatory status in pediatric sickle cell disease: Unravelling the role of immune cell subsets. Front Mol Biosci; 9. Epub ahead of print 10 January 2023. https:\/\/doi.org\/10.3389\/fmolb.2022.1075686","DOI":"10.3389\/fmolb.2022.1075686"},{"key":"60783_CR48","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3324\/haematol.2022.281587","volume":"108","author":"A Nardo-Marino","year":"2022","unstructured":"Nardo-Marino, A. & Brousse, V. Splenectomy in sickle cell disease: do benefits outweigh risks? Haematologica 108, 954\u2013955 (2022).","journal-title":"Haematologica"},{"key":"60783_CR49","doi-asserted-by":"crossref","first-page":"796837","DOI":"10.3389\/fphys.2022.796837","volume":"13","author":"S Peretz","year":"2022","unstructured":"Peretz, S. et al. The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia\/hyposplenism and hypersplenism. Front. Physiol. 13, 796837 (2022).","journal-title":"Front. Physiol."},{"key":"60783_CR50","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ncomms1265","volume":"2","author":"RE Howes","year":"2011","unstructured":"Howes, R. E. et al. The global distribution of the Duffy blood group. Nat. Commun. 2, 266 (2011).","journal-title":"Nat. Commun."},{"key":"60783_CR51","doi-asserted-by":"publisher","unstructured":"Zheng, Y. et al. Impact of Duffy Status on Neutrophil Counts and Clinical Outcomes in Pediatric Patients With Sickle Cell Disease. https:\/\/doi.org\/10.1002\/ajh.27748","DOI":"10.1002\/ajh.27748"},{"key":"60783_CR52","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/bloodadvances.2024014399","volume":"9","author":"MR Hysong","year":"2025","unstructured":"Hysong, M. R. et al. Characterization of the phenotypic consequences of the Duffy-null genotype. Blood Adv. 9, 1452\u20131462 (2025).","journal-title":"Blood Adv."},{"key":"60783_CR53","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1182\/blood-2009-05-221382","volume":"115","author":"RB Schnabel","year":"2010","unstructured":"Schnabel, R. B. et al. Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood 115, 5289\u20135299 (2010).","journal-title":"Blood"},{"key":"60783_CR54","unstructured":"Maheshwari, A. & Killeen, R. B. Duffy Blood Group System. In: StatPearls. Treasure Island (FL): StatPearls Publishing, (2026). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK580473\/ accessed 1 June 2026)."},{"key":"60783_CR55","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1182\/blood-2023-182459","volume":"142","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y. et al. Duffy-Null Patients with Sickle Cell Disease Are at Risk for Low Neutrophil Counts with HU Treatment. Blood 142, 1125\u20131125 (2023).","journal-title":"Blood"},{"key":"60783_CR56","doi-asserted-by":"crossref","first-page":"e099049","DOI":"10.1136\/bmjopen-2025-099049","volume":"15","author":"E Asiimwe","year":"2025","unstructured":"Asiimwe, E. et al. Duffy-null variant and practical implications for patient care: a scoping review. BMJ Open. 15, e099049 (2025).","journal-title":"BMJ Open."},{"key":"60783_CR57","doi-asserted-by":"crossref","first-page":"954054","DOI":"10.3389\/fimmu.2023.954054","volume":"14","author":"LK Siransy","year":"2023","unstructured":"Siransy, L. K. et al. Are IL-1 family cytokines important in management of sickle cell disease in Sub-Saharan Africa patients? Front. Immunol. 14, 954054 (2023).","journal-title":"Front. Immunol."},{"key":"60783_CR58","doi-asserted-by":"publisher","unstructured":"Silva-Junior, A. L. et al. Immunological Hallmarks of Inflammatory Status in Vaso-Occlusive Crisis of Sickle Cell Anemia Patients. Front Immunol; 12. Epub ahead of print 11 March 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.559925","DOI":"10.3389\/fimmu.2021.559925"},{"key":"60783_CR59","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00277-020-03978-8","volume":"99","author":"IF Domingos","year":"2020","unstructured":"Domingos, I. F. et al. High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia. Ann. Hematol. 99, 947\u2013953 (2020).","journal-title":"Ann. Hematol."},{"key":"60783_CR60","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ajh.23736","volume":"89","author":"S Sarray","year":"2014","unstructured":"Sarray, S. et al. Reduction in serum IL-10 levels is a surrogate marker for predicting vaso-occlusive crisis in sickle cell disease. Am. J. Hematol. 89, 789\u2013790 (2014).","journal-title":"Am. J. Hematol."},{"key":"60783_CR61","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jha2.712","volume":"4","author":"ICP Gomes","year":"2023","unstructured":"Gomes, I. C. P. et al. Levels of inflammatory markers are differentially expressed in sickle cell anemia and sickle cell trait. EJHaem 4, 705\u2013709 (2023).","journal-title":"EJHaem"},{"key":"60783_CR62","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.joen.2014.11.016","volume":"41","author":"SBP Ferreira","year":"2015","unstructured":"Ferreira, S. B. P. et al. Periapical cytokine expression in sickle cell disease. J. Endod. 41, 358\u2013362 (2015).","journal-title":"J. Endod"},{"key":"60783_CR63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cyto.2013.10.009","volume":"65","author":"ICJ Bandeira","year":"2014","unstructured":"Bandeira, I. C. J. et al. Chronic inflammatory state in sickle cell anemia patients is associated with HBB(*)S haplotype. Cytokine 65, 217\u2013221 (2014).","journal-title":"Cytokine"},{"key":"60783_CR64","first-page":"65","volume":"22","author":"WN Ibraheim","year":"2023","unstructured":"Ibraheim, W. N., Jasim, H. \u0410. & Abdullah, \u0410. S. The impact of interferon-gamma level on the health status of patients with sickle cell disease in Basrah. \u0412\u043e\u043f\u0440\u043e\u0441\u044b \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\/\u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0438\u043c\u043c\u0443\u043d\u043e\u043f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0432 \u043f\u0435\u0434\u0438\u0430\u0442\u0440\u0438\u0438. 22, 65\u201367 (2023).","journal-title":"\u0412\u043e\u043f\u0440\u043e\u0441\u044b \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438\/\u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u0438\u043c\u043c\u0443\u043d\u043e\u043f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u0432 \u043f\u0435\u0434\u0438\u0430\u0442\u0440\u0438\u0438"},{"key":"60783_CR65","doi-asserted-by":"crossref","first-page":"1068260","DOI":"10.3389\/fimmu.2022.1068260","volume":"13","author":"I-H Huang","year":"2022","unstructured":"Huang, I-H. et al. JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review. Front. Immunol. 13, 1068260 (2022).","journal-title":"Front. Immunol."},{"key":"60783_CR66","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.3324\/haematol.2017.177360","volume":"103","author":"RR Penkert","year":"2018","unstructured":"Penkert, R. R. et al. Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia. Haematologica 103, e50\u2013e54 (2018).","journal-title":"Haematologica"},{"key":"60783_CR67","unstructured":"American Journal of Hematology | Blood Research Journal | Wiley Online & Library April, (2026). https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ajh.70193 (accessed 3."},{"key":"60783_CR68","unstructured":"Hypoxia, I. & Cytokine Crosstalk in Sickle Cell Disease. April, and : From Mechanisms to Modulation- A Narrative Review - PubMed, (2026). https:\/\/pubmed.ncbi.nlm.nih.gov\/40901617\/ (accessed 3."},{"key":"60783_CR69","doi-asserted-by":"crossref","first-page":"e0010341","DOI":"10.1371\/journal.pntd.0010341","volume":"16","author":"G Katawa","year":"2022","unstructured":"Katawa, G. et al. Anti-Th17 and anti-Th2 responses effects of hydro-ethanolic extracts of Aframomum melegueta, Khaya senegalensis and Xylopia aethiopica in hyperreactive onchocerciasis individuals\u2019 peripheral blood mononuclear cells. PLoS Negl. Trop. Dis. 16, e0010341 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"60783_CR70","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13104-025-07150-1","volume":"18","author":"YR Konu","year":"2025","unstructured":"Konu, Y. R. et al. Hemoglobin phenotypes of children attending pediatric clinics in Lom\u00e9, Togo, 2022. BMC Res. Notes. 18, 76 (2025).","journal-title":"BMC Res. Notes"},{"key":"60783_CR71","doi-asserted-by":"crossref","first-page":"163","DOI":"10.31486\/toj.20.0061","volume":"21","author":"CN Tchopba","year":"2021","unstructured":"Tchopba, C. N. et al. Systemic T Cell Subsets and Cytokines in Patients With Homozygous Sickle Cell Disease and Asymptomatic Urinary Tract Infections in Togo. Ochsner J. 21, 163\u2013172 (2021).","journal-title":"Ochsner J."},{"key":"60783_CR72","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5489\/cuaj.687","volume":"5","author":"S Dason","year":"2011","unstructured":"Dason, S., Dason, J. T. & Kapoor, A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can. Urol. Assoc. J. 5, 316\u2013322 (2011).","journal-title":"Can. Urol. Assoc. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60783-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60783-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60783-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:56:11Z","timestamp":1792061771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60783-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60783"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60783-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the \u00ab Comit\u00e9 de Bio\u00e9thique pour la Recherche en Sant\u00e9 \u00bb (CBRS), Lom\u00e9, Togo, under the Ministry of Health, Public Hygiene, and Universal Access to Care (Opinion N\n                      o\n                      036\/2022\/CBRS, dated October 27, 2022). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki. Written informed consent was obtained from the parents or legal guardians of all participating children, and verbal assent was obtained from the children prior to their inclusion in the study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The parents or guardians of the study participants gave their informed written consent for the publication of the data, as their identities will remain confidential.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"32324"}}